OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Evgeny Rogaev

1 Projects | 1 Researchers | $342,429 Invested

2017

University of Massachusetts Boston

Evgeny Rogaev, PhD

Targeting APOE e4 in Alzheimer's Disease by novel RNA-based therapeutic compounds

  • Funding Amount: $342,429
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: zzAPOE
  • Status: Closed